VYNE: VYNE Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 32.43
Enterprise Value ($M) 1.81
Book Value ($M) 88.73
Book Value / Share 6.29
Price / Book 0.37
NCAV ($M) 87.01
NCAV / Share 6.17
Price / NCAV 0.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.81
Return on Equity (ROE) -1.08

Liquidity (mrq)
Quick Ratio 12.73
Current Ratio 12.73

Balance Sheet (mrq) ($M)
Current Assets 95.96
Assets 97.69
Liabilities 8.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.42
Operating Income -29.26
Net Income -28.45
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -25.34
Cash from Investing -57.35
Cash from Financing 82.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Citadel Advisors Llc 8.50
02-02 13G/A Soleus Capital Master Fund, L.P. 5.00 -20.99
11-13 13D AI Biotechnology LLC 19.99
11-13 13G Cormorant Asset Management, LP 9.99
11-13 13G Eventide Asset Management, Llc 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 1,844 18,327 10.06
2024-04-18 2,879 3,201 89.94
2024-04-17 3,912 31,265 12.51
2024-04-16 12,197 33,106 36.84
2024-04-15 6,251 58,530 10.68

(click for more detail)

Similar Companies
VTGN – Vistagen Therapeutics, Inc. VTVT – vTv Therapeutics Inc.
VXRT – Vaxart, Inc. WINT – Windtree Therapeutics, Inc.
XBIO – Xenetic Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io